Blog Posts

Defending Market Share in Pharma

Posted by | Fuld & Company

Pharmaceutical firms frequently need to defend their market position against rivals’ competitive strategy. Threats to leading therapies can come in many forms:

  • A structurally similar compound or generic variant is entering the market, aiming to compete with your brand on efficacy, safety, or price
  • A drug with a new mechanism of action has generated considerable excitement, and patients are expected to switch to the novel drug
  • An established product in a related indication may be moving into your market due to a label expansion
  • An existing competitor has begun targeting your product with negative claims

Competitive intelligence (CI) and strategic planning provide pharmaceutical firms with actionable counter-measures to protect market share, retain customers, and minimize the impact of aggressive direct competition.

Tags: , , ,

Related Resources

Read More

How escalation in the Middle East may lead to turmoil in oil markets

Oil is a geopolitical commodity usually sensitive to major geopolitical or military developments, especially  in the Middle East. Yet, the […]

Read More

Shell reorients its energy transition plan

It looks like Shell is considering1 selling battery management and utility company sonnen, which it acquired in 2019. Although the […]

Read More

Will AI impact your job?

Highlights from the Collision Conference Collision Conference 2023 was a four-day event that brought together more than 600 speakers, thousands […]

Subscribe to our mailing list for our latest updates: